Structures by: Glidewell C.
Total: 1 449
1-Phenyl-1<i>H</i>-pyrazole-3,4-dicarboxylic acid
C11H8N2O4
Acta Crystallographica Section E (2018) 74, 12 1783-1789
a=13.164(2)Å b=7.4692(9)Å c=21.173(3)Å
α=90° β=90° γ=90°
Dimethyl 1-phenyl-1<i>H</i>-pyrazole-3,4-dicarboxylate
C13H12N2O4
Acta Crystallographica Section E (2018) 74, 12 1783-1789
a=5.9000(4)Å b=14.5273(12)Å c=14.8726(12)Å
α=90° β=98.867(3)° γ=90°
1-(4-Methoxyphenyl)-1<i>H</i>-pyrazole-3,4-dicarbohydrazide
C12H14N6O3
Acta Crystallographica Section E (2018) 74, 12 1783-1789
a=7.6030(6)Å b=22.6605(19)Å c=7.6751(7)Å
α=90° β=102.284(3)° γ=90°
Tris(2,2'-bipyridine)iron(II) bis(1,1,3,3-tetracyano-2-methoxypropenide) 0.776-hydrate
C30H24FeN62,2(C8H3N4O),0.776(H2O)
Acta Crystallographica Section E (2018) 74, 12 1717-1726
a=38.3410(3)Å b=11.27560(10)Å c=19.33740(16)Å
α=90° β=97.5030(10)° γ=90°
Tris(2,2'-bipyridine)iron(II) 1,1,3,3-tetracyano-2-(propylsulfanyl)propenide perchlorate
C30H24FeN62,C10H7N4S,ClO4
Acta Crystallographica Section E (2018) 74, 12 1717-1726
a=11.6644(3)Å b=23.1692(4)Å c=13.9599(3)Å
α=90° β=97.202(2)° γ=90°
Tris(5,5'-dimethyl-2,2'-bipyridine)iron(II) 1,1,3,3-tetracyano-2-methoxypropenide tetrafluoridoborate ethanol 0.926-solvate
C36H36FeN62,C8H3N4O,BF4,0.926(C2H6O)
Acta Crystallographica Section E (2018) 74, 12 1717-1726
a=11.6979(4)Å b=25.7716(7)Å c=14.1055(4)Å
α=90° β=100.444(3)° γ=90°
Tris(5,5'-dimethyl-2,2'-bipyridine)iron(II) 1,1,3,3-tetracyano-2-propoxypropenide tetrafluoridoborate
C36H36FeN62,C10H7N4O,BF4
Acta Crystallographica Section E (2018) 74, 12 1717-1726
a=11.6246(5)Å b=14.2404(6)Å c=14.3224(6)Å
α=65.340(2)° β=76.040(3)° γ=87.571(3)°
Clozapinium 3,5-dinitrobenzoate dimethyl sulfoxide monosolvate
C18H20ClN4,C7H3N2O6,C2H6OS
Acta Crystallographica Section E (2015) 71, 4 406-413
a=15.3593(2)Å b=15.7685(2)Å c=11.8679(2)Å
α=90° β=91.8097(14)° γ=90°
Clozapinium hydrogen maleate 0.21-hydrate
C18H20ClN4,C4H3O4,0.21(H2O)
Acta Crystallographica Section E (2015) 71, 4 406-413
a=9.7166(3)Å b=9.9699(2)Å c=23.1059(6)Å
α=90° β=96.800(3)° γ=90°
Clozapinium 2-hydroxybenzoate
C18H20ClN4,C7H5O3
Acta Crystallographica Section E (2015) 71, 4 406-413
a=17.4296(5)Å b=15.3728(5)Å c=8.6359(3)Å
α=90° β=90.325(3)° γ=90°
Methyl 5-bromo-2-[(2-chloroquinolin-3-yl)methoxy]benzoate
C18H13BrClNO3
Acta Crystallographica Section E (2015) 71, 6 609-617
a=7.3185(4)Å b=18.4177(7)Å c=11.7870(5)Å
α=90° β=93.609(4)° γ=90°
2-Chloro-3-[(naphthalen-1-yloxy)methyl]quinoline
C20H14ClNO
Acta Crystallographica Section E (2015) 71, 6 609-617
a=5.3165(3)Å b=10.5098(4)Å c=13.6201(7)Å
α=90° β=98.527(5)° γ=90°
Methyl 5-bromo-2-[(2-chloro-6-methylquinolin-3-yl)methoxy]benzoate
C19H15BrClNO3
Acta Crystallographica Section E (2015) 71, 6 609-617
a=15.1920(3)Å b=11.98641(19)Å c=19.0307(3)Å
α=90° β=90° γ=90°
Methyl 2-[(2-chloro-6-methylquinolin-3-yl)methoxy]benzoate
C19H16ClNO3
Acta Crystallographica Section E (2015) 71, 6 609-617
a=13.5860(3)Å b=15.5857(2)Å c=30.9389(5)Å
α=90° β=90° γ=90°
{5-[(2-Chloroquinolin-3-yl)methoxy]-4-(hydroxymethyl)-6-methyl-pyridin-3-yl}methanol
C18H17ClN2O3
Acta Crystallographica Section E (2015) 71, 6 609-617
a=9.7866(3)Å b=15.3336(4)Å c=10.6570(3)Å
α=90° β=92.381(3)° γ=90°
3-Chloro-2-(4-methylphenyl)-2<i>H</i>-pyrazolo[3,4-<i>b</i>]quinoline
C17H12ClN3
Acta Crystallographica Section E (2015) 71, 5 567-570
a=10.2194(4)Å b=13.4661(5)Å c=10.4600(4)Å
α=90° β=102.780(4)° γ=90°
2,2'-Bipyridin-1-ium 1,1,3,3-tetracyano-2-ethoxyprop-2-en-1-ide
C10H9N2,C9H5N4O
Acta Crystallographica Section E (2015) 71, 5 509-515
a=7.25140(10)Å b=10.6647(2)Å c=11.5619(2)Å
α=100.0200(10)° β=104.3720(10)° γ=92.5900(10)°
Bis(2,2'-bipyridin-1-ium) 1,1,3,3-tetracyano-2-(dicyanomethylene)propane-1,3-diide
2(C10H9N2),C10N62
Acta Crystallographica Section E (2015) 71, 5 509-515
a=13.4195(8)Å b=16.1801(8)Å c=12.9058(9)Å
α=90° β=116.721(3)° γ=90°
2-Chloro-3-(dimethoxymethyl)-6-methoxyquinoline
C13H14ClNO3
Acta Crystallographica Section E (2015) 71, 5 o364-o365
a=27.1156(9)Å b=7.1401(3)Å c=13.0804(5)Å
α=90° β=90° γ=90°
(<i>E</i>)-2-Fluorobenzaldehyde (pyridin-2-yl)hydrazone
C12H10FN3
Acta Crystallographica Section E (2015) 71, 5 o362-o363
a=3.85166(14)Å b=23.1757(7)Å c=11.4227(4)Å
α=90° β=99.278(4)° γ=90°
2-(4-Chlorophenyl)-<i>N</i>-(2-iodophenyl)acetamide
C14H11ClINO
Acta Crystallographica Section E (2016) 72, 9 1270-1275
a=24.0010(10)Å b=6.2369(3)Å c=9.3266(4)Å
α=90° β=99.621(2)° γ=90°
2-(4-Chlorophenyl)-<i>N</i>-(pyrazin-2-yl)acetamide
C12H10ClN3O
Acta Crystallographica Section E (2016) 72, 9 1270-1275
a=10.7041(4)Å b=7.5724(3)Å c=28.6619(11)Å
α=90° β=90° γ=90°
[Tris(4,4-bipyridine)]diium bis(1,1,3,3-tetracyano-2-ethoxypropenide) trihydrate
C30H26N62,2(C9H5N4O),3(H2O)
Acta Crystallographica Section E (2016) 72, 9 1246-1250
a=18.1861(2)Å b=7.11870(10)Å c=35.7070(4)Å
α=90° β=100.4480(10)° γ=90°
<i>meso</i>-Di-μ-chlorido-bis[bis(2,2-bipyridine)cadmium] bis(1,1,3,3-tetracyano-2-ethoxypropenide) 0.81-hydrate
C40H32Cd2Cl2N82,2(C9H5N4O),0.806(H2O)
Acta Crystallographica Section E (2017) 73, 1 48-52
a=12.425(5)Å b=13.912(5)Å c=17.382(5)Å
α=90° β=104.395(5)° γ=90°
Bis(tri-2-pyridylamine)iron(II) bis(perchlorate)
C30H24FeN82,2(ClO4)
Acta Crystallographica Section E (2018) 74, 5 668-672
a=8.3251(7)Å b=17.4731(11)Å c=11.0495(9)Å
α=90° β=98.716(7)° γ=90°
[3-(2-Chloro-9<i>H</i>-thioxanthen-9-yl)propyl]dimethylammonium hydrogen bis(3,5-dinitrobenzoate)
C18H19ClNS,C7H3N2O6,C7H4N2O6
Acta Crystallographica Section E (2019) 75, 2 292-298
a=11.3454(8)Å b=24.3857(16)Å c=11.6098(8)Å
α=90° β=93.6910(10)° γ=90°
1-(2-Iodobenzoyl)-4-(pyrimidin-2-yl)piperazine
C15H15IN4O
Acta Crystallographica Section E (2019) 75, 2 129-133
a=9.6417(17)Å b=13.604(2)Å c=12.174(2)Å
α=90° β=105.155(2)° γ=90°
1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,6-difluorobenzoyl)piperazine
C19H18F2N2O3
Acta Crystallographica Section E (2019) 75, 2 202-207
a=14.2762(9)Å b=15.9821(10)Å c=7.3753(5)Å
α=90° β=90° γ=90°
1-[(1,3-Benzodioxol-5-yl)methyl]-4-(3-fluorobenzoyl)piperazine
C19H19FN2O3
Acta Crystallographica Section E (2019) 75, 2 202-207
a=12.2358(16)Å b=10.3185(14)Å c=14.2310(19)Å
α=90° β=111.199(2)° γ=90°
1-[(1,3-Benzodioxol-5-yl)methyl]-4-(2,4-dichlorobenzoyl)piperazine
C19H18Cl2N2O3
Acta Crystallographica Section E (2019) 75, 2 202-207
a=12.2889(14)Å b=12.3034(14)Å c=13.3667(15)Å
α=90° β=116.2950(10)° γ=90°
(<i>RS</i>)-7-Chloro-2-(2,5-dimethoxyphenyl)-2,3-dihydroquinazolin-4(1<i>H</i>)-one
C16H15ClN2O3
Acta Crystallographica Section E (2019) 75, 6 843-847
a=15.314(7)Å b=15.314(7)Å c=25.736(12)Å
α=90° β=90° γ=90°
4-(4-Methoxyphenyl)piperazin-1-ium 4-chlorobenzoate monohydrate
C11H17N2O,C7H4ClO2,H2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=6.2110(10)Å b=7.4810(10)Å c=20.144(4)Å
α=84.90(2)° β=87.48(2)° γ=85.19(2)°
4-(4-Methoxyphenyl)piperazin-1-ium benzoate monohydrate
C11H17N2O,C7H5O2,H2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=6.2150(10)Å b=7.5470(10)Å c=18.716(4)Å
α=84.34(2)° β=87.14(2)° γ=84.69(2)°
4-(4-Methoxyphenyl)piperazin-1-ium 4-fluorobenzoate monohydrate
C11H17N2O,C7H4FO2,H2O
Acta Crystallographica Section E (2019) 75, 10 1494-1506
a=6.2560(10)Å b=7.4890(10)Å c=19.097(2)Å
α=84.190(10)° β=86.98(2)° γ=84.62(2)°
1-Benzoyl-4-(4-methoxyphenyl)piperazine
C18H20N2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=29.403(5)Å b=7.9811(14)Å c=6.7898(13)Å
α=90° β=97.352(12)° γ=90°
1-(2-Fluorobenzoyl)-4-(4-methoxyphenyl)piperazine
C18H19FN2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=6.998(2)Å b=7.938(2)Å c=28.415(6)Å
α=90° β=92.20(3)° γ=90°
1-(2-Chlorobenzoyl)-4-(4-methoxyphenyl)piperazine
C18H19ClN2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=13.0320(11)Å b=13.2470(13)Å c=19.258(2)Å
α=90° β=90° γ=90°
1-(2-Iodobenzoyl)-4-(4-methoxyphenyl)piperazine
C18H19IN2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=12.7671(13)Å b=13.5429(12)Å c=20.2542(16)Å
α=90° β=90° γ=90°
1-(2-Hydroxybenzoyl)-4-(4-methoxyphenyl)piperazine
C18H20N2O3
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=9.7265(6)Å b=12.9084(9)Å c=24.8610(10)Å
α=90° β=90° γ=90°
1-(2-Bromoobenzoyl)-4-(4-methoxyphenyl)piperazine
C18H19BrN2O2
Acta Crystallographica Section E (2019) 75, 8 1253-1260
a=12.9119(14)Å b=13.3664(16)Å c=19.5019(19)Å
α=90° β=90° γ=90°
(2<i>E</i>)-1-(5-Chlorothiophen-2-yl)-3-(2-methylphenyl)prop-2-en-1-one
C14H11ClOS
Acta Crystallographica Section E (2016) 72, 8 1153-1158
a=14.7179(7)Å b=7.5783(4)Å c=11.5451(5)Å
α=90° β=102.999(4)° γ=90°
2-Benzoylamino-<i>N</i>'-(4-hydroxybenzylidene)-3-(thiophen-2-yl)prop-2-enohydrazide
C21H17N3O3S
Acta Crystallographica Section E (2016) 72, 8 1099-1102
a=22.5212(7)Å b=10.1879(4)Å c=17.3592(5)Å
α=90° β=105.801(3)° γ=90°
(2<i>E</i>)-1-(Anthracen-9-yl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one
C26H22O
Acta Crystallographica Section E (2016) 72, 8 1153-1158
a=9.0150(4)Å b=14.0601(6)Å c=16.2611(8)Å
α=105.146(4)° β=95.967(4)° γ=98.057(4)°
6-Hydroxy-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4(3<i>H</i>)-one
C15H12N4O4
Acta Crystallographica Section E (2016) 72, 7 969-971
a=12.1863(9)Å b=10.7079(8)Å c=11.1726(8)Å
α=90° β=105.412(8)° γ=90°
2-Amino-4,4,7,7-tetramethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium benzoate
C11H19N2S,C7H5O2
Acta Crystallographica Section E (2017) 73, 9 1320-1325
a=10.6089(3)Å b=22.7141(5)Å c=8.8959(2)Å
α=90° β=122.2110(10)° γ=90°
2-Amino-4,4,7,7-tetramethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium picrate
C11H19N2S,C6H2N3O7
Acta Crystallographica Section E (2017) 73, 9 1320-1325
a=10.7928(2)Å b=6.95910(10)Å c=28.0176(5)Å
α=90° β=97.4080(10)° γ=90°
<i>N</i>-(4-chlorobenzylidene)-2-hydroxyaniline
C13H10ClNO
Acta Crystallographica Section E (2018) 74, 3 376-379
a=13.0830(17)Å b=5.8746(6)Å c=14.825(2)Å
α=90° β=101.521(4)° γ=90°
(<i>RS</i>)-(4-Chlorophenyl)(pyridin-2-yl)methanol
C12H10ClNO
Acta Crystallographica Section E (2016) 72, 1 69-72
a=8.4309(6)Å b=16.1488(11)Å c=8.6878(6)Å
α=90° β=112.994(2)° γ=90°
Ethyl (1<i>RS</i>,6<i>SR</i>)-4-(2-methyl-1<i>H</i>-imidazol-4-yl)-2-oxo-6-(2,3,5-trichlorophenyl)cyclohex-3-ene-1-carboxylate
C19H17Cl3N2O3
Acta Crystallographica Section E (2016) 72, 1 31-34
a=9.753(5)Å b=10.029(6)Å c=11.099(5)Å
α=106.281(4)° β=96.420(5)° γ=104.913(5)°
3-Benzoyl-2-[(5-bromo-2-hydroxy-3-methoxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene
C23H20BrNO3S
Acta Crystallographica Section E (2015) 71, 2 176-179
a=4.81267(18)Å b=22.1919(8)Å c=18.7012(7)Å
α=90° β=97.392(3)° γ=90°
4-Amino-3-methyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C3H6N4S
Acta Crystallographica Section E (2015) 71, 9 1003-1009
a=8.8682(6)Å b=9.8230(6)Å c=6.5427(4)Å
α=90° β=90° γ=90°
4-[(<i>E</i>)-(3,4-Dimethoxybenzylidene)amino]-3-methyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C12H14N4O2S
Acta Crystallographica Section E (2015) 71, 9 1003-1009
a=7.3112(4)Å b=16.0793(9)Å c=22.8994(13)Å
α=90° β=90° γ=90°
4-[(<i>E</i>)-(5-Bromo-2-hydroxybenzylidene)amino]-3-methyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C10H9BrN4OS
Acta Crystallographica Section E (2015) 71, 9 1003-1009
a=4.4122(4)Å b=14.7450(13)Å c=18.7911(16)Å
α=90° β=95.828(3)° γ=90°
(2<i>E</i>)-1-(5-Chlorothiophen-2-yl)-3-(4-ethylphenyl)prop-2-en-1-one
C15H13ClOS
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=6.0154(5)Å b=8.6358(5)Å c=14.0548(9)Å
α=74.428(5)° β=88.225(6)° γ=70.417(6)°
(2E)-1-(5-Bromothiophen-2-yl)-3-(4-ethylphenyl)prop-2-en-1-one
C15H13BrOS
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=5.9745(6)Å b=8.6636(7)Å c=14.3039(12)Å
α=74.731(7)° β=88.146(7)° γ=70.334(8)°
(2<i>E</i>)-1-(5-Chlorothiophen-2-yl)-3-(4-ethoxyphenyl)prop-2-en-1-one
C15H13ClO2S
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=16.3577(6)Å b=7.4518(4)Å c=11.0892(4)Å
α=90° β=92.260(3)° γ=90°
(2<i>E</i>)-1-(5-Chlorothiophen-2-yl)-3-(4-bromophenyl)prop-2-en-1-one
C13H8BrClOS
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=6.0152(8)Å b=8.5691(12)Å c=13.1824(9)Å
α=75.250(10)° β=81.446(8)° γ=70.281(12)°
(2<i>E</i>)-1-(5-Bromothiophen-2-yl)-3-(3-methoxyphenyl)prop-2-en-1-one
C14H11BrO2S
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=9.2726(6)Å b=11.3948(8)Å c=12.1472(7)Å
α=90° β=93.273(6)° γ=90°
(1<i>RS</i>,2'<i>RS</i>,3<i>SR</i>,7a'<i>SR</i>)-2'-Benzoyl-1-hexyl-2-oxo-\ 1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizine]-1'-carboxylic acid
C28H32N2O4
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1109-1115
a=19.9182(9)Å b=19.9182(9)Å c=19.9182(9)Å
α=116.980(2)° β=116.980(2)° γ=116.980(2)°
(1'<i>RS</i>,2'<i>RS</i>,3<i>SR</i>,7a'<i>SR</i>)-1',2'-Bis(4-chlorobenzoyl)-5,7-dichloro-2-oxo-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizine] dichloromethane 0.981-solvate
C28H20Cl4N2O3,0.981(CH2Cl2)
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1109-1115
a=12.800(4)Å b=12.511(5)Å c=18.638(5)Å
α=90° β=99.325(12)° γ=90°
(<i>E</i>)-3-(2-Bromophenyl)-2-(1-methyl-1<i>H</i>-indole-3-carbonyl)acrylonitrile
C19H13BrN2O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=9.188(5)Å b=9.308(5)Å c=10.887(5)Å
α=113.56(2)° β=90.782(18)° γ=116.173(16)°
(2<i>RS</i>)-2-(2-Bromobenzyl)-3-(1-methyl-1<i>H</i>-indol-3-yl)-\ 3-oxopropanenitrile
C19H15BrN2O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=13.728(6)Å b=14.901(6)Å c=15.507(6)Å
α=90° β=92.165(19)° γ=90°
(<i>E</i>)-1-(1-Acetyl-1<i>H</i>-indol-3-yl)-3-(2-bromophenyl)-2-cyanoprop-1-en-1-yl acetate
C22H17BrN2O3
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=19.406(9)Å b=8.773(4)Å c=23.028(9)Å
α=90° β=103.318(15)° γ=90°
(2<i>RS</i>)-3-(1-benzyl-1<i>H</i>-indol-3-yl)-\ 2-(2-bromobenzyl)-3-oxopropanenitrile
C25H19BrN2O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=10.912(4)Å b=12.544(8)Å c=15.583(7)Å
α=89.23(4)° β=79.49(3)° γ=73.20(3)°
2-Benzoyl-3-(2-bromophenyl)acrylonitrile
C16H10BrNO
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=10.986(4)Å b=8.977(4)Å c=13.209(5)Å
α=90° β=97.140(17)° γ=90°
(<i>E</i>)-1-(1-Benzyl-1<i>H</i>-indol-3-yl)-3-(2-bromophenyl)-2-cyanoprop-1-en-1-yl benzoate
C32H23BrN2O2
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 12 1040-1049
a=14.886(4)Å b=8.129(3)Å c=21.432(6)Å
α=90° β=104.638(12)° γ=90°
(<i>E</i>)-3-{5-[Benzyl(methyl)amino]-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl}-1-(4-bromophenyl)prop-2-en-1-one
C27H24BrN3O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 784-790
a=31.172(16)Å b=10.039(6)Å c=17.861(10)Å
α=90° β=123.334(14)° γ=90°
5-[Benzyl(methyl)amino]-3-methyl-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C19H19N3O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 784-790
a=7.811(4)Å b=17.951(9)Å c=11.405(6)Å
α=90° β=92.36(2)° γ=90°
(3<i>RS</i>)-5'-[Benzyl(methyl)amino]-3'-methyl-1',5-diphenyl-3,4-dihydro-1'<i>H</i>,2<i>H</i>-[3,4'-bipyrazole]-2-carbaldehyde
C28H27N5O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 784-790
a=11.321(5)Å b=21.572(13)Å c=9.550(5)Å
α=90° β=97.711(18)° γ=90°
(3<i>RS</i>)-2-acetyl-5'-[Benzyl(methyl)amino]- 5-(4-methoxyphenyl)-3'-methyl-1'-phenyl-3,4-dihydro-1'<i>H</i>,2<i>H</i>-[3,4'-bipyrazole] ethanol 0.945-solvate
C30H31N5O2,0.945C2H6O
Acta crystallographica. Section C, Structural chemistry (2017) 73, Pt 10 784-790
a=9.363(6)Å b=28.238(18)Å c=10.775(7)Å
α=90° β=97.04(2)° γ=90°
2-Ethylsulfanyl-7-(furan-2-yl)-4-(thiophen-2-yl)pyrazolo[1,5-<i>a</i>][1,3,5]triazine
C15H12N4OS2
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 908-911
a=7.4999(4)Å b=8.8965(5)Å c=11.2806(9)Å
α=83.338(6)° β=73.354(5)° γ=86.406(6)°
6-(2-Chlorophenyl)-2-methylimidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C11H8ClN3S
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 920-926
a=7.5567(3)Å b=11.4589(5)Å c=24.9006(11)Å
α=90° β=90° γ=90°
6-(2-Chlorophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C10H6ClN3S
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 920-926
a=7.5805(4)Å b=9.7942(5)Å c=13.6175(6)Å
α=97.712(2)° β=96.549(2)° γ=99.416(2)°
6-(3,4-Dichlorophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C10H5Cl2N3S
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 920-926
a=5.5186(2)Å b=7.5194(3)Å c=12.8406(5)Å
α=102.027(2)° β=91.293(2)° γ=98.430(2)°
6-(4-Fluoro-3-methoxyphenyl)-2-methylimidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C12H10FN3OS
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 920-926
a=8.6766(3)Å b=11.7888(4)Å c=12.5227(4)Å
α=103.039(2)° β=95.189(2)° γ=110.365(2)°
<i>N</i>-(4-Chloro-3-methylphenyl)-2-phenylacetamide
C15H14ClNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=5.0039(7)Å b=10.7525(12)Å c=12.6177(12)Å
α=108.615(10)° β=91.771(11)° γ=90.167(11)°
<i>N</i>-(4-Chloro-3-methylphenyl)-2-(2,4-dichlorophenyl)acetamide
C15H12Cl3NO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=11.8441(7)Å b=4.7288(3)Å c=13.0981(7)Å
α=90° β=101.310(6)° γ=90°
<i>N</i>-(4-Bromo-3-methylphenyl)-2-phenylacetamide
C15H14BrNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=4.9995(3)Å b=10.8392(4)Å c=12.7301(7)Å
α=108.149(4)° β=91.968(5)° γ=90.310(4)°
<i>N</i>-(4-Bromo-3-methylphenyl)-2-(2-chlorophenyl)acetamide
C15H13BrClNO
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 889-894
a=11.8458(8)Å b=4.7282(3)Å c=25.0757(15)Å
α=90° β=98.133(5)° γ=90°
(<i>E</i>)-1-{3-[(5-Fluoro-2-hydroxybenzylidene)amino]phenyl}ethanone
C15H12FNO2
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1835-1839
a=14.9527(5)Å b=5.5152(2)Å c=16.6918(5)Å
α=90° β=114.739(2)° γ=90°
(<i>E</i>)-1-{3-[(2-Hydroxy-3-methoxybenzylidene)amino]phenyl}ethanone
C16H15NO3
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1835-1839
a=19.1904(4)Å b=5.33856(12)Å c=26.5678(6)Å
α=90° β=90° γ=90°
4-(Benzhydryloxy)-1-[4-(4-<i>tert</i>-butylphenyl)-4-oxobutyl]piperidinium 3,5-dinitrobenzoate
C32H40NO2,C7H3N2O6
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1513-1516
a=5.9168(3)Å b=28.3733(12)Å c=21.0782(11)Å
α=90° β=97.836(5)° γ=90°
<i>N</i>,<i>N</i>-Dimethyl-[2-(2,2-diphenyl)-2-prop-2-ynyloxyacetoxy]ethylamine
C21H23NO3
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1488-1492
a=9.2545(9)Å b=21.7246(19)Å c=9.4531(9)Å
α=90° β=94.763(9)° γ=90°
<i>N</i>,<i>N</i>-Dimethyl-[2-(2,2-diphenyl)-2-prop-2-ynyloxy\ acetoxy]ethylammonium 2,4,6-trinitrophenolate
C21H24NO3,C6H2N3O7
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1488-1492
a=7.5208(3)Å b=8.3919(3)Å c=22.2282(7)Å
α=85.099(3)° β=84.294(3)° γ=75.117(3)°
2-Methoxycarbonyl-4-nitroacetanilide
C10H10N2O5
Acta Crystallographica Section E (2004) 60, 5 o852-o854
a=16.4482(14)Å b=19.9095(17)Å c=6.7549(6)Å
α=90.00° β=90.00° γ=90.00°
4-Bromo-β-(2-oxoquinolin-4-yloxy)cinnamonitrile
C18H11BrN2O2
Acta Crystallographica Section E (2006) 62, 7 o3056-o3058
a=8.9860(2)Å b=12.4111(3)Å c=13.6138(3)Å
α=90.00° β=92.006(2)° γ=90.00°
Glyoxal 3-nitrophenylhydrazone
C8H7N3O3
Acta Crystallographica Section E (2006) 62, 5 o1816-o1818
a=7.4737(4)Å b=19.7711(13)Å c=6.0262(4)Å
α=90.00° β=107.080(4)° γ=90.00°
2-Nitrophenylacetic acid
C8H7NO4
Acta Crystallographica Section E (2006) 62, 5 o1915-o1917
a=9.3182(3)Å b=9.4466(2)Å c=9.9733(3)Å
α=90.00° β=114.7990(17)° γ=90.00°
Glyoxal 2-nitrophenylhydrazone
C8H7N3O3
Acta Crystallographica Section E (2006) 62, 6 o2204-o2206
a=18.670(4)Å b=3.7723(4)Å c=23.896(5)Å
α=90.00° β=96.429(6)° γ=90.00°
1-(4-Methylphenylsulfonyl)-1H-1,2,3-benzotriazole
C13H11N3O2S
Acta Crystallographica Section E (2005) 61, 9 o2795-o2797
a=7.4211(3)Å b=9.2176(3)Å c=9.7823(3)Å
α=98.614(3)° β=104.249(2)° γ=102.684(3)°
Bis-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3,4,5-trimethoxyphenylmethane
C30H32N6O3
Acta Crystallographica Section E (2004) 60, 6 o1034-o1037
a=9.7540(2)Å b=33.4646(7)Å c=8.90100(10)Å
α=90.00° β=103.6020(9)° γ=90.00°
Rac-5-Acetyl-6-(4-nitrophenyl)-6,7-dihydro-5H-1,3-dioxolo[4,5-g]quinoline-8-one
C18H14N2O6
Acta Crystallographica Section E (2004) 60, 6 o1057-o1059
a=6.5253(2)Å b=21.4286(5)Å c=10.8198(9)Å
α=90.00° β=90.00° γ=90.00°
11-(4-bromophenyl)-10-methyl-8-phenyl-6,8-dihydro-5H- benzo[f]pyrazolo[3,4-b]quinoline
C27H20BrN3
Acta Crystallographica Section E (2005) 61, 6 o1702-o1703
a=7.0237(3)Å b=12.8964(7)Å c=13.3517(7)Å
α=106.630(3)° β=101.423(3)° γ=102.274(3)°
(1R,2R)-N,N'-bis(4-nitrophenylmethylene)cyclohexane-1,2-diamine
C20H20N4O4
Acta Crystallographica Section E (2005) 61, 6 o1699-o1701
a=52.275(3)Å b=5.3605(2)Å c=14.0209(8)Å
α=90.00° β=104.952(2)° γ=90.00°
Saccharin
C7H5NO3S
Acta Crystallographica Section E (2005) 61, 6 o1944-o1946
a=9.4722(4)Å b=6.9227(2)Å c=11.7322(3)Å
α=90.00° β=103.203(3)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-1,5-di-2-thienylpentane-1,5-dione
C23H19ClN2O2S2
Acta Crystallographica Section E (2005) 61, 6 o1892-o1894
a=14.6729(5)Å b=17.8962(6)Å c=16.2619(3)Å
α=90.00° β=90.00° γ=90.00°
Α-Tris(2,4-pentanedionato-κ^2^O,O)vanadium(III)
C15H21O6V
Acta Crystallographica Section E (2005) 61, 7 m1326-m1328
a=13.3920(7)Å b=16.4043(6)Å c=15.1901(10)Å
α=90.00° β=90.00° γ=90.00°
3,5-Dimethyl-1,7-diphenyl-1,7-dihydrodipyrazolo[3,4-b,4',3'-e]pyridine
C21H17N5
Acta Crystallographica Section E (2006) 62, 5 o1676-o1678
a=21.2976(4)Å b=10.9267(3)Å c=7.4201(2)Å
α=90.00° β=98.108(2)° γ=90.00°
N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4-oxopyrimidin-2-yl)glycylglycinate
C9H12N6O5
Acta Crystallographica Section E (2002) 58, 8 o942-o945
a=7.4727(6)Å b=8.2356(4)Å c=9.6678(8)Å
α=81.208(5)° β=88.722(3)° γ=76.169(4)°
5-(2-Acetyloxyphenyl)-3-phenyl-1,2,4-oxadiazole
C16H12N2O3
Acta Crystallographica Section E (2003) 59, 11 o1729-o1730
a=14.5489(8)Å b=5.4293(3)Å c=17.2806(13)Å
α=90.00° β=105.955(2)° γ=90.00°